CytomX Therapeutics Inc (CTMX) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 78 people. CytomX Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap
' category with current market capitalization of 1.1 B. CytomX Therapeutics Inc has 38.41 M outstanding shares of which 1.1 M shares are currently shorted by private and institutional investors with about 3.65 trading days to cover.
CytomX Therapeutics currently holds about 331.28 M in cash with 150.31 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.62.
Check CytomX Therapeutics Probability Of Bankruptcy